Acquisition Alignment Recent acquisition by Akkodis suggests Raland’s regulatory and quality expertise may be integrated into a broader digital engineering and smart industry services portfolio, presenting cross-sell opportunities to Akkodis’ existing life sciences clients and expanded service scopes.

Global Reach Established presence across multiple states and international projects (28 states and 26 countries) indicates readiness to scale regulatory and compliance programs for multinational pharma, biotech, and medical device accounts—targeting global expansion initiatives.

Regulatory Core Specialization in quality, regulatory, and compliance consulting combined with clinical auditing capabilities positions Raland to upsell end-to-end lifecycle services, including GMP/GLP readiness, inspections, and cyber/quality integration projects.

Mid-Market Focus With a revenue range of 25M-50M and a lean employee base, Raland appeals to mid-market life sciences firms seeking hands-on, full-service regulatory support, offering an opportunity for scalable managed services and retainer-based engagements.

Tech Enabled Adoption of ISO 13485, SCADA, Confluence, Jira, and other collaboration tools signals capability to modernize compliance programs through digital solutions, offering data-driven regulatory analytics, automation pilots, and scalable documentation platforms.